首页|期刊导航|中国药物经济学|瑞舒伐他汀钙片强化治疗老年冠状动脉粥样硬化性心脏病对患者血脂代谢与动脉内皮功能及炎症介质的影响

瑞舒伐他汀钙片强化治疗老年冠状动脉粥样硬化性心脏病对患者血脂代谢与动脉内皮功能及炎症介质的影响OA

Effects of Rosuvastatin Calcium Tablets on Lipid Metabolism,Arterial Endothelial Function and Inflammatory Mediators in Patients with Coronary Atherosclerotic Heart Disease

中文摘要英文摘要

目的 探讨瑞舒伐他汀钙片强化剂量(20 mg/d)对比常规剂量(5 mg/d)治疗老年冠状动脉粥样硬化性心脏病对患者血脂代谢、动脉内皮功能及炎症介质的影响.方法 选取2024 年5 月至2025 年10 月辽宁省金秋医院收治的老年冠状动脉粥样硬化性心脏病患者130 例作为研究对象,依照随机数字表法分为对照组和观察组,每组65 例.入组患者均接受基础对症治疗,对照组采用常规剂量(5 mg/d)瑞舒伐他汀钙片治疗,观察组采用强化剂量(20 mg/d)瑞舒伐他汀钙片治疗.比较两组患者血脂[甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]、动脉内皮功能[血管性血友病因子(vWF)、血栓调节蛋白(TM)、内皮素(ET)]、炎症介质[超敏-C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)]、治疗效果、不良反应.结果 治疗4、8、12 周后两组TG、TC、LDL-C水平均降低,HDL-C 水平均升高,且观察组各项指标均优于对照组,差异有统计学意义(P<0.05).治疗 4、8、12 周后两组vWF、TM、ET水平均降低,且观察组下降幅度均大于对照组,差异有统计学意义(P<0.05).治疗4、8、12 周后两组hs-CRP、TNF-α、IL-8 水平均降低,且观察组均低于对照组,差异有统计学意义(P<0.05).观察组治疗有效率高于对照组(P<0.05).观察组不良反应发生率6.15%(4/65)与对照组4.62%(3/65)比较差异无统计学意义(P>0.05).结论 瑞舒伐他汀钙片20 mg/d强化治疗老年冠状动脉粥样硬化性心脏病患者的临床疗效优于5 mg/d常规剂量,可有效调节血脂代谢,改善动脉内皮功能,减轻炎症反应,且未观察到明显严重不良反应.

Objective To explore the effects of the intensified dosage of rosuvastatin calcium tablets(20 mg/day)compared with the conventional dosage(5 mg/day)on lipid metabolism,arterial endothelial function and inflammatory mediators in elderly patients with coronary atherosclerotic heart disease.Methods A total of 130 elderly patients with coronary heart disease admitted to Jinqiu Hospital in Liaoning Province from May 2024 to October 2025 were selected as the research subjects.They were divided into the control group and the observation group according to the random number table method,with 65 cases in each group.All the enrolled patients received basic symptomatic treatment.The control group was treated with the conventional dose(5 mg/d)of rosuvastatin calcium tablets,while the observation group was treated with the enhanced dose(20 mg/d)of rosuvastatin calcium tablets.The lipid levels[triglycerides(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C)],arterial endothelial function[von Willebrand factor(vWF),thrombomodulin(TM),endothelin(ET)],inflammatory mediators[high-sensitivity C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α),interleukin-8(IL-8)],treatment effects,and adverse reactions were compared between the two groups.Results After 4,8,and 12 weeks of treatment,the levels of TG,TC,and LDL-C in both groups decreased,while the level of HDL-C increased.Moreover,the indicators in the observation group were all better than those in the control group,and the differences were statistically significant(P<0.05).After 4,8,and 12 weeks of treatment,the levels of vWF,TM,and ET in both groups decreased,and the decrease in the observation group was greater than that in the control group,with statistically significant differences(P<0.05).After 4,8,and 12 weeks of treatment,the levels of hs-CRP,TNF-α,and IL-8 in both groups decreased,and the levels in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).The effective rate of treatment in the observation group was higher than that in the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the observation group(6.15%,4/65)and the control group(4.62%,3/65)(P>0.05).Conclusion The clinical efficacy of rosuvastatin calcium tablets at a dose of 20 mg/day in the intensive treatment of elderly patients with coronary atherosclerotic heart disease is superior to that of the conventional dose of 5 mg/day.It can effectively regulate lipid metabolism,improve arterial endothelial function,and alleviate inflammatory responses,and no obvious serious adverse reactions were observed.

杨济睿;林芳

辽宁省金秋医院药学部,沈阳 110016辽宁省金秋医院心内一科,沈阳 110016

医药卫生

冠状动脉粥样硬化性心脏病瑞舒伐他汀钙片强化治疗动脉内皮功能血脂

Coronary atherosclerotic heart diseaseRosuvastatin calcium tabletsIntensified treatmentArterial endothelial functionBlood lipid

《中国药物经济学》 2026 (6)

65-69,5

10.12010/j.issn.1673-5846.2026.06.012

评论